Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-07 @ 4:47 PM
Study NCT ID:
NCT04447092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2020-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
Sponsor:
Organization: